Park Square Financial Group’s GSK GSK Stock Holding History

Park Square Financial Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-177	Closed	-$5.99K	–	277
2025 Q4	$5.99K	Buy	+177	New	+$8.26K	0.04%	182
2025 Q3	–	Sell	-607	Closed	-$23.3K	–	549
2025 Q2	$23.3K	Buy	607 +178	+41%	+$6.8K	0.02%	427
2025 Q1	$16.6K	Buy	429 +173	+68%	+$6.33K	0.01%	484
2024 Q4	$8.66K	Buy	+256	New	+$9.22K	0.01%	611

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Park Square Financial Group's GSK Position: Q1 2026 in Review

Park Square Financial Group sold out of GSK (GSK) in Q1 2026, closing a stake of 177 shares — an estimated $5.99K sold.

Park Square Financial Group first reported a position in GSK in Q4 2024 and held it in 4 quarters. The position peaked at $23.3K in Q2 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Park Square Financial Group reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Park Square Financial Group sold 177 GSK shares in Q1 2026, an estimated $5.99K.
Park Square Financial Group first reported a position in GSK in Q4 2024 and held it in 4 quarters.
Park Square Financial Group's GSK position peaked at $23.3K in Q2 2025.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Park Square Financial Group's 13F filing for Q1 2026, filed 13 May 2026.